Literature DB >> 11736981

Response of atypical symptoms of gastro-oesophageal reflux to antireflux surgery.

T M Farrell1, W S Richardson, T L Trus, C D Smith, J G Hunter.   

Abstract

BACKGROUND: Atypical manifestations of gastro-oesophageal reflux (GOR) include asthma, chest pain, cough and hoarseness. The effectiveness of antireflux surgery for these symptoms is uncertain. The present study compared symptomatic response rates for typical and atypical GOR symptoms after fundoplication.
METHODS: Between October 1991 and January 1998, 324 patients underwent laparoscopic fundoplication at Emory University Hospital and returned postoperative questionnaires. Severity of typical (heartburn) and atypical (asthma, chest pain, cough and hoarseness) GOR symptoms was reported by patients on a 0-4 scale before surgery, and at 6 and 52 weeks after operation. Patients were stratified based on preoperative symptoms into three groups: group 1 (severe heartburn/minimal atypical symptoms), group 2 (severe heartburn/severe atypical symptoms) and group 3 (minimal heartburn/severe atypical symptoms).
RESULTS: In group 1 (n = 173) heartburn improved in 99 per cent and resolved in 87 per cent. In group 2 (n = 95) heartburn improved in 95 per cent and resolved in 76 per cent, and atypical symptoms improved in 94 per cent and resolved in 42 per cent. In group 3 (n = 56) atypical symptoms improved in 93 per cent and resolved in 48 per cent. Although all symptoms were improved by fundoplication, resolution was more likely for heartburn than for atypical symptoms.
CONCLUSION: Atypical symptoms of GOR are improved by fundoplication, but symptom resolution occurs in fewer than 50 per cent of patients.

Entities:  

Mesh:

Year:  2001        PMID: 11736981     DOI: 10.1046/j.0007-1323.2001.01949.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  21 in total

1.  24-h multichannel intraluminal impedance-pH monitoring may be an inadequate test for detecting gastroesophageal reflux in patients with mixed typical and atypical symptoms.

Authors:  Michelle S Han; Michal J Lada; Dylan R Nieman; Andreas Tschoner; Christian G Peyre; Carolyn E Jones; Thomas J Watson; Jeffrey H Peters
Journal:  Surg Endosc       Date:  2014-11-15       Impact factor: 4.584

2.  SAGES Appropriateness Conference: a summary.

Authors:  R E Glasgow; A Fingerhut; J Hunter
Journal:  Surg Endosc       Date:  2003-09-29       Impact factor: 4.584

3.  A poor response to proton pump inhibition is not a contraindication for laparoscopic antireflux surgery for gastro esophageal reflux disease.

Authors:  P M Wilkerson; J Stratford; L Jones; J Sohanpal; M I Booth; T C B Dehn
Journal:  Surg Endosc       Date:  2005-07-14       Impact factor: 4.584

4.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2002

5.  Airway reflux, cough and respiratory disease.

Authors:  Ian D Molyneux; Alyn H Morice
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

6.  Treatment of GORD: Three decades of progress and disappointments.

Authors:  Jean Paul Galmiche; Frank Zerbib; Stanislas Bruley des Varannes
Journal:  United European Gastroenterol J       Date:  2013-06       Impact factor: 4.623

7.  Laparoscopic antireflux surgery in patients with throat symptoms: a word of caution.

Authors:  Dharmendran Ratnasingam; Tanya Irvine; Sarah K Thompson; David I Watson
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

8.  Long-term outcomes of laparoscopic antireflux surgery for gastroesophageal reflux disease (GERD)-related airway disorder.

Authors:  J A Kaufman; J E Houghland; E Quiroga; M Cahill; C A Pellegrini; B K Oelschlager
Journal:  Surg Endosc       Date:  2006-12       Impact factor: 4.584

9.  Noncardiac chest pain: current treatment.

Authors:  Ron Schey; Autumn Villarreal; Ronnie Fass
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-04

10.  Outcome of surgical fundoplication for extra-oesophageal symptoms of reflux.

Authors:  Mohd Iqbal; A J Batch; Krishna Moorthy; B T Cooper; R T Spychal
Journal:  Surg Endosc       Date:  2008-03-26       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.